Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | MME | P08473 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | FPR2 | P25090 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 4/20 | 0.48 |
| ▸ | MMP9 | P14780 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | CPA1 | P15085 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7517173 | 1.00 | NPSR1 (0.62) | NPSR1MMEALDH1A1MAPTFPR2 | |
| SCHEMBL28290972 | 1.00 | NPSR1 (0.62) | NPSR1MMEALDH1A1MAPTFPR2 | |
| Diethylamine SCHEMBL29197173 | 0.91 | NPSR1 (0.54) | NPSR1MMEALDH1A1MAPTFPR2 | |
| Diethylamine SCHEMBL29197175 | 0.91 | NPSR1 (0.54) | NPSR1MMEALDH1A1MAPTFPR2 | |
| SCHEMBL6212171 | 0.91 | NPSR1 (0.52) | NPSR1MMENAALAD2ACEL3MBTL1 | |
| SCHEMBL14343041 | 0.91 | NPSR1 (0.52) | NPSR1MMENAALAD2ACEL3MBTL1 | |
| SCHEMBL14343061 | 0.83 | PPARG (0.47) | NPSR1FPR2 | |
| SCHEMBL21095472 | 0.83 | ABCB1 (0.46) | NPSR1MMEALDH1A1MAPTFPR2 | |
| SCHEMBL1899106 | 0.82 | NPSR1 (0.45) | NPSR1MME | |
| SCHEMBL993651 | 0.82 | NPSR1 (0.45) | NPSR1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109701013-B | Targeted nano drug delivery system and preparation method thereof | 安徽工程大学 | 2021-07-13 | — | — | CN | claimed |
| CN-109701013-A | A kind of targeted nanometer drug delivery system and preparation method | 安徽工程大学 | 2019-05-03 | — | — | CN | claimed |
| CN-109701013-B | Targeted nano drug delivery system and preparation method thereof | 安徽工程大学 | 2021-07-13 | — | — | CN | disclosed |
| CN-109701013-A | A kind of targeted nanometer drug delivery system and preparation method | 安徽工程大学 | 2019-05-03 | — | — | CN | disclosed |
| EP-0699665-B1 | Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists | LILLY CO ELI (US) | 2003-03-05 | — | — | EP | disclosed |
| CN-1098106-C | Anthracycline conjugates, their preparation and their use as antitumor agents | PHAMACIA & UPJOHN S P A (IT) | 2003-01-08 | — | — | CN | disclosed |
| US-6175013-B1 | 1-(2-METHOXYBENZYL)-2-((4-PHENYL-1-PIPERAZINYL)METHYL)-4-(1H -INDOL-3-YLMETHYL)-2-IMIDAZOLINE, FOR EXAMPLE; ADMINSTERING TO TREAT ANXIETY, DEPRESSION, PSYCHOSIS, AND SCHIZOPHRENIA | ELI LILLY AND COMPANY | 2001-01-16 | — | — | US | disclosed |
| EP-0699665-A1 | Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists | ELI LILLY AND COMPANY (US) | 1996-03-06 | — | — | EP | disclosed |
| CN-1108454-A | Anthracycline conjugates, their preparation and their use as antitumor agents | ERBA CARLO SPA (IT) | 1995-09-13 | — | — | CN | disclosed |